The Pharmacology of Pancuronium Bromide (ORG.NA97), a New Potent Steroidal Neuromuscular Blocking Agent

British Journal of Pharmacology and Chemotherapy
doi 10.1111/j.1476-5381.1968.tb00466.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Pancuronium Bromide Induced Joint Contractures in the Newborn

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
1984English

Extended Neuromuscular Blockade With Mivacurium Following Pancuronium

European Journal of Anaesthesiology
AnesthesiologyPain Medicine
1996English

Non-Steroidal Neuromuscular Blocking Agents to Re-Establish Paralysis After Reversal of Rocuronium-Induced Neuromuscular Block With Sugammadex

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2008English

Clinical Pharmacology of a New Antithrombotic Agent, Ticlo

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1978English

The Phase 1 Study of Bucumolol, a New Β-Blocking Agent

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1980English

2-(Diphenylmethoxymethyl)-Imidazoline, a New Potent Antihistamine Agent.

Acta Chemica Scandinavica
1947English

Hemodynamic Effects of Tilisolol, a New .BETA.-adrenergic Blocking Agent With Vasodilating Property, and Doxazosin, a New .ALPHA.-adrenergic Blocking Agent, in Essential Hypertension.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1988English

Avoidance vs Use of Neuromuscular Blocking Agent for Improving Conditions During Tracheal Intubation: A Cochrane Systematic Review

British Journal of Anaesthesia
AnesthesiologyPain Medicine
2018English

Potentiation of Pancuronium and Vecuronium Neuromuscular Blockade by Intravenous Salbutamol

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy